Absorption |
Blood-Brain Barrier | BBB- | 0.9856 |
Human Intestinal Absorption | HIA+ | 0.9919 |
Caco-2 Permeability | Caco2- | 0.5416 |
P-glycoprotein Substrate | Substrate | 0.8953 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8699 |
Non-inhibitor | 0.8383 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7933 |
Distribution |
Subcellular localization | Lysosome | 0.6388 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8591 |
CYP450 2D6 Substrate | Non-substrate | 0.9116 |
CYP450 3A4 Substrate | Non-substrate | 0.7284 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9046 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9330 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8497 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.6283 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8282 |
Non-inhibitor | 0.6392 |
AMES Toxicity | AMES toxic | 0.9107 |
Carcinogens | Non-carcinogens | 0.7701 |
Fish Toxicity | High FHMT | 0.9990 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9774 |
Honey Bee Toxicity | Low HBT | 0.8868 |
Biodegradation | Not ready biodegradable | 1.0000 |
Acute Oral Toxicity | III | 0.7797 |
Carcinogenicity (Three-class) | Non-required | 0.6142 |